Related Experiment Video
Updated: Jun 23, 2026

MicroRNA Detection in Prostate Tumors by Quantitative Real-time PCR (qPCR)
Published on: May 16, 2012
MicroRNAs and their potential for translation in prostate cancer
Ralph W DeVere White1, Ruth L Vinall, Clifford G Tepper
1Department of Urology, University of California, Davis, School of Medicine, Sacramento, CA 95817, USA. rwdeverewhite@ucdavis.edu
Objective:
Patients die of prostate cancer (CaP) because predictably after a period of response to androgen withdrawal, their CaP becomes castrate resistant. In this paper, we discuss the role that microRNAs (miRNAs) may play in this process.
Methods:
miRNAs are a group of endogenous, small non-coding RNA molecules that are thought to be responsible for the regulation of up to 30% of gene expression. The miRNA expression profile between androgen responsive and castrate resistant CaP cell lines is compared. Functional studies were carried out to identify the importance of the miRNA targets in controlling this process.
Results:
There were 17 differentially expressed miRNAs found, 10 up-regulated and 7 down-regulated. Among these, miRNA-125b was found to have the ability of rendering LNCaP cells resistant to androgen withdrawal. It was found to be androgen regulated and one of its targets, BAK1, was identified as being involved in how these CaP cells undergo apoptosis functionally.
Conclusion:
miRNA-125b, at least in the CaP cell lines tested, is involved in the development of castrate resistance. While clearly this miRNA is only part of the answer, miRNAs may lead us in a new direction in trying to solve the central problem in CaP.
Insights
MicroRNAs (miRNAs) are implicated in prostate cancer (CaP) castrate resistance. Specifically, miRNA-125b promotes androgen independence in CaP cells by affecting apoptosis, offering new therapeutic targets.
Area of Science:
- Molecular Biology
- Oncology
- Genetics
Background:
- Prostate cancer (CaP) often becomes resistant to androgen withdrawal therapy.
- MicroRNAs (miRNAs) are small non-coding RNAs regulating gene expression.
- Understanding CaP castrate resistance mechanisms is crucial for patient survival.
Purpose of the Study:
- To investigate the role of microRNAs (miRNAs) in the development of castrate-resistant prostate cancer (CaP).
- To compare miRNA expression profiles in androgen-responsive versus castrate-resistant CaP cell lines.
- To identify specific miRNAs and their targets involved in CaP progression.
Main Methods:
- Comparative analysis of miRNA expression profiles in CaP cell lines.
- Functional studies to assess the impact of miRNAs on androgen sensitivity.
- Identification and validation of miRNA targets involved in apoptosis.
Main Results:
- Seventeen differentially expressed miRNAs were identified (10 up-regulated, 7 down-regulated).
- miRNA-125b was found to induce androgen resistance in LNCaP cells.
- The target BAK1 was identified as a key player in CaP cell apoptosis regulation by miRNA-125b.
Conclusions:
- miRNA-125b plays a significant role in the development of castrate resistance in tested CaP cell lines.
- miRNAs represent a promising new avenue for therapeutic strategies against CaP.
- Further research into miRNA's role could unlock novel treatments for advanced prostate cancer.
Related Concept Videos
MicroRNAs
MicroRNAs
Leaky Scanning

